PRESS RELEASE published on 12/16/2024 at 07:00, 1 year 10 months ago Andrea Kleiner appointed Head of Business Clients at Baloise Andrea Kleiner appointed Head of Business Clients at Baloise. With a background in insurance and extensive managerial experience, she will join Baloise's Executive Committee in Switzerland on 1 April 2025 Insurance Executive Committee Baloise Business Clients Andrea Kleiner
BRIEF published on 12/09/2024 at 07:05, 1 year 10 months ago Changes in the Board of Directors of Baloise Holding Ltd. Board Of Directors Insurance Appointments Financial Markets Baloise Holding
PRESS RELEASE published on 12/09/2024 at 07:00, 1 year 10 months ago Changes to the Board of Directors of Baloise Holding Ltd Changes to the Board of Directors announced at the 2025 Annual General Meeting of Baloise Holding Ltd to enhance insurance and financial market expertise Board Of Directors Annual General Meeting Insurance Financial Markets Baloise Holding Ltd
BRIEF published on 11/27/2024 at 09:05, 1 year 11 months ago Travel and family, life priorities of the Swiss according to Baloise Financial Security Life Goals Swiss Population Travel And Family Risk Appetite
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 11 months ago Travel, family and financial security: the top life goals of the Swiss Swiss people set travel, family, and financial security as top life goals. Baloise survey reveals insights on risk, inspiration sources, goal achievement, and financial planning Financial Planning Swiss Life Goals Risk Appetite Baloise Survey
BRIEF published on 11/26/2024 at 09:05, 1 year 11 months ago Charles Ischi AG Wins InnoPrix SO! Award for Pharmaceutical Innovation Pharmaceutical Innovation Charles Ischi AG DISI Evo Tester InnoPrix SO! Solothurn Region
PRESS RELEASE published on 11/26/2024 at 09:00, 1 year 11 months ago Charles Ischi AG wins the 2024 InnoPrix SO! award for its innovative pharmaceutical tester Charles Ischi AG wins the 2024 InnoPrix SO! award for its innovative pharmaceutical tester, the DISI Evo, revolutionizing medication disintegration time measurement Charles Ischi AG InnoPrix SO! Pharmaceutical Tester DISI Evo Medication Disintegration
BRIEF published on 11/20/2024 at 07:05, 1 year 11 months ago Baloise Projects CHF 550 Million Cash Remittance Amid Refocusing Strategy Strategy Baloise Cash Remittance Insurance Growth Capital Base
BRIEF published on 11/20/2024 at 07:05, 1 year 11 months ago Baloise Implements Refocusing Strategy Amid Financial Adjustments Share Buy-back Cash Remittance SST Ratio Non-life Growth Baloise Strategy
PRESS RELEASE published on 11/20/2024 at 07:00, 1 year 11 months ago Baloise is implementing its refocusing strategy – cash remittance of over CHF 550 million expected Baloise Holding AG implements refocusing strategy with CHF 550 million cash remittance expected. First milestones reached, solid financial targets set Business Growth Financial Targets Baloise Refocusing Strategy Cash Remittance
Published on 11/03/2026 at 08:00, 13 minutes ago Caledonia Mining Corporation Plc Notice of Q3 2026 Results and Investor Presentation
Published on 11/02/2026 at 23:15, 8 hours 58 minutes ago ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 9 hours 43 minutes ago Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 15 hours 13 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/03/2026 at 08:05, 7 minutes ago Freedom24 plans Geneva office for Q1 2027, deepening ties with Swiss finance and research
Published on 11/03/2026 at 08:00, 13 minutes ago 2CRSi SA: Binding order of over €60 million1: 2CRSi to deliver 83 NVIDIA HGX B300 AI servers to Exaion by the end of 2026
Published on 11/03/2026 at 08:00, 13 minutes ago V-ZUG expands its international presence in Scandinavia
Published on 11/03/2026 at 07:55, 18 minutes ago Schaeffler announces further performance improvement program
Published on 11/03/2026 at 07:00, 1 hour 13 minutes ago bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 18:30, 13 hours 43 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 13 hours 55 minutes ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 14 hours 13 minutes ago Covivio - Information on total number of voting rights and share capital
